Showing results (11-20 of 131) with videos related to
Sort By:
Pageof 14
Neurobiology of Pain (Cambridge, Mass.)|March 5, 2025
Critical reflections on medication overuse headache in patients with migraine: An unsolved riddle in nociceptionAlberto Chiarugi, Daniela BuonvicinoTrends in Molecular Medicine|November 15, 2011
Targeting poly(ADP-ribose) polymerase-1 as a promising approach for immunomodulation in multiple sclerosis?Leonardo Cavone, Alberto ChiarugiThe FEBS Journal|December 18, 2008
Post-ischemic brain damage: targeting PARP-1 within the ischemic neurovascular units as a realistic avenue to stroke treatmentFlavio Moroni, Alberto ChiarugiPain and Therapy|November 1, 2015
Recent Advances in Pediatric Use of Oral Paracetamol in Fever and Pain ManagementMaurizio de Martino, Alberto ChiarugiJournal of Neurochemistry|April 5, 2003
Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disordersAlberto Chiarugi, Michael A MoskowitzBiochemical Pharmacology|May 12, 2009
Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivoLaura Formentini, Flavio Moroni, Alberto ChiarugiNeuroscience|April 16, 2021
Treatment with Non-specific HDAC Inhibitors Administered after Disease Onset does not Delay Evolution in a Mouse Model of Progressive Multiple SclerosisDaniela Buonvicino, Giuseppe Ranieri, Alberto ChiarugiNeurotoxicity Research|January 21, 2021
Cuprizone-Dependent De/Remyelination Responses and Functional Correlates in Mouse Strains Adopted to Model Relapsing, Chronic and Progressive Experimental Autoimmune EncephalomyelitisDaniela Buonvicino, Giuseppe Ranieri, Alberto ChiarugiJournal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 6, 2012
AMP-dependent hypothermia affords protection from ischemic brain injuryMirko Muzzi, Francesco Blasi, Alberto ChiarugiMolecular Medicine (Cambridge, Mass.)|March 5, 2011
The therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosisGiuseppe Faraco, Leonardo Cavone, Alberto ChiarugiPageof 14